Literature DB >> 27301585

Antimicrobial use and microbiological testing in district general hospital ICUs of the Veneto region of north-east Italy.

P Benedetti1, A M Sefton2, M Menegozzo3, C Guerriero4, G Bordignon5, G Da Rin6, C Romualdi7, G Pellizzer8, D M Livermore9.   

Abstract

International - predominantly American - studies undertaken in the ICUs of teaching centres show that inadequate antibiotic therapy increases mortality and length of stay. We sought to ascertain whether this also pertains to smaller ICUs in the Veneto region of north-east Italy. To the best of our knowledge, this is the first such survey in the Veneto area or in Italy as a whole. A retrospective, observational study was performed across five general-hospital ICUs to examine appropriateness of microbiological sampling, empirical antibiotic adequacy, and outcomes. Among 911 patients (mean age, 65.8 years ± 16.2 SD; median ICU stay, 17.0 days [IQR, 8.0-29.0]), 757 (83.1 %) were given empirical antibiotics. Treatment adequacy could be fully assessed in only 212 patients (28.0 %), who received empirical treatment and who had a relevant clinical sample collected at the initiation of this antibiotic (T0). Many other patients only had delayed microbiological investigation of their infections between day 1 and day 10 of therapy. Mortality was significantly higher among the 34.9 % of patients receiving inadequate treatment (48.6 % vs 18.80 %; p < 0.001). Only 32.5 % of combination regimens comprised a broad-spectrum Gram-negative β-lactam plus an anti-MRSA agent, and many combinations were irrational. Inadequate treatment was frequent and was strongly associated with mortality; moreover, there was delayed microbiological investigation of many infections, precluding appropriate treatment modification and de-escalation. Improvements in these aspects and in antibiotic stewardship are being sought.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27301585     DOI: 10.1007/s10096-016-2701-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  41 in total

Review 1.  Healthcare-associated infection prevention in pediatric intensive care units: a review.

Authors:  N Joram; L de Saint Blanquat; D Stamm; E Launay; C Gras-Le Guen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

2.  Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.

Authors:  Barbara Albiger; Corinna Glasner; Marc J Struelens; Hajo Grundmann; Dominique L Monnet
Journal:  Euro Surveill       Date:  2015

3.  Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis.

Authors:  Ilias I Siempos; Konstantinos Z Vardakas; Christos E Kyriakopoulos; Theodora K Ntaidou; Matthew E Falagas
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

4.  Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.

Authors:  Daniel P Raymond; Shawn J Pelletier; Traves D Crabtree; Heather L Evans; Timothy L Pruett; Robert G Sawyer
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

5.  Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.

Authors:  J F Moroney; A E Fiore; L H Harrison; J E Patterson; M M Farley; J H Jorgensen; M Phelan; R R Facklam; M S Cetron; R F Breiman; M Kolczak; A Schuchat
Journal:  Clin Infect Dis       Date:  2001-08-10       Impact factor: 9.079

6.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

7.  Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.

Authors:  Paolo Malacarne; Carlotta Rossi; Guido Bertolini
Journal:  J Antimicrob Chemother       Date:  2004-06-09       Impact factor: 5.790

8.  Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.

Authors:  David L Paterson; Wen-Chien Ko; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Robert A Bonomo; Louis B Rice; Marilyn M Wagener; Joseph G McCormack; Victor L Yu
Journal:  Clin Infect Dis       Date:  2004-06-08       Impact factor: 9.079

9.  The impact of antimicrobial resistance on health and economic outcomes.

Authors:  Sara E Cosgrove; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2003-05-16       Impact factor: 9.079

Review 10.  Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit.

Authors:  Andrew F Shorr
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.